Skip to main content
. Author manuscript; available in PMC: 2017 Oct 21.
Published in final edited form as: Eur J Med Chem. 2016 Jun 13;122:102–117. doi: 10.1016/j.ejmech.2016.06.015

Table 3.

The design and synthesis of dihydropyran-fused oridonin derivatives as potential anticancer agents.

graphic file with name nihms798211u3.jpg
Compd R EC50 (μM)
MCF-7 MDA-MB-231 MDA-MB-468 MCF-7/ADR
1 - 4.4 28.0 5.3 34.8
Adriamycin - 0.7 2.3 0.7 > 10
32 graphic file with name nihms798211t11.jpg 2.4 3.7 5.8 6.8
33 graphic file with name nihms798211t12.jpg 0.44 0.54 0.52 1.6
34 graphic file with name nihms798211t13.jpg 5.8 8.2 7.0 10.3
35 graphic file with name nihms798211t14.jpg 2.1 3.3 4.4 3.2
36 graphic file with name nihms798211t15.jpg 6.8 7.2 7.3 8.7
37 graphic file with name nihms798211t16.jpg 2.4 2.2 3.0 3.8
38 graphic file with name nihms798211t17.jpg 3.5 6.1 5.4 4.7
39 graphic file with name nihms798211t18.jpg 2.2 1.8 2.6 4.4
40 graphic file with name nihms798211t19.jpg 4.3 7.1 4.9 4.3
41 graphic file with name nihms798211t20.jpg 2.3 3.3 3.0 3.1